IMPROVED MEDICINAL FORM OF INTERFERON INDUCTOR

biochemistry, pharmacy. SUBSTANCE: invention relates to the improved medicinal form, suppositorium. Suppositorium has a double-strand complex of polyribouridylic and polyriboadenylic acids as interferon inductor, 200-250 mcg; hyaluronic acid, 10-20 mg; mixture of vitamins C and E as antioxidants, 30...

Full description

Saved in:
Bibliographic Details
Main Authors FADEEVA L.L, KASPAROV A.A, SAMOJLENKO I.I, SEMENOVA T.B
Format Patent
LanguageEnglish
Published 10.02.2001
Subjects
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online AccessGet full text

Cover

Abstract biochemistry, pharmacy. SUBSTANCE: invention relates to the improved medicinal form, suppositorium. Suppositorium has a double-strand complex of polyribouridylic and polyriboadenylic acids as interferon inductor, 200-250 mcg; hyaluronic acid, 10-20 mg; mixture of vitamins C and E as antioxidants, 30-40 mg and base up to 1.5 g. Mass ratio of vitamins C and E in the mixture of antioxidants is 1:1 preferably. Novel medicinal form is used in treatment of patients with viral diseases of different etiology and provides the dosed release of an active component. EFFECT: improved quality, enhanced effectiveness, absence of adverse effects. 2 cl, 5 ex
AbstractList biochemistry, pharmacy. SUBSTANCE: invention relates to the improved medicinal form, suppositorium. Suppositorium has a double-strand complex of polyribouridylic and polyriboadenylic acids as interferon inductor, 200-250 mcg; hyaluronic acid, 10-20 mg; mixture of vitamins C and E as antioxidants, 30-40 mg and base up to 1.5 g. Mass ratio of vitamins C and E in the mixture of antioxidants is 1:1 preferably. Novel medicinal form is used in treatment of patients with viral diseases of different etiology and provides the dosed release of an active component. EFFECT: improved quality, enhanced effectiveness, absence of adverse effects. 2 cl, 5 ex
Author FADEEVA L.L
SAMOJLENKO I.I
KASPAROV A.A
SEMENOVA T.B
Author_xml – fullname: FADEEVA L.L
– fullname: KASPAROV A.A
– fullname: SAMOJLENKO I.I
– fullname: SEMENOVA T.B
BookMark eNrjYmDJy89L5WTQ8_QNCPIPc3VR8HV18XT29HP0UXDzD_JV8HdT8PQLcQ1ycw3y9wMyXUKdQ_yDeBhY0xJzilN5oTQ3g4Kba4izh25qQX58anFBYnJqXmpJfFCokaGZkZmFubORMRFKAJdhJ14
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
ExternalDocumentID RU2162687C2
GroupedDBID EVB
ID FETCH-epo_espacenet_RU2162687C23
IEDL.DBID EVB
IngestDate Fri Jul 19 12:29:37 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_RU2162687C23
Notes Application Number: RU19980101738
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20010210&DB=EPODOC&CC=RU&NR=2162687C2
ParticipantIDs epo_espacenet_RU2162687C2
PublicationCentury 2000
PublicationDate 20010210
PublicationDateYYYYMMDD 2001-02-10
PublicationDate_xml – month: 02
  year: 2001
  text: 20010210
  day: 10
PublicationDecade 2000
PublicationYear 2001
RelatedCompanies BARINSKIJ IGOR' FELIKSOVICH
SAMOJLENKO IGOR' INNOKENT'EVICH
RelatedCompanies_xml – name: BARINSKIJ IGOR' FELIKSOVICH
– name: SAMOJLENKO IGOR' INNOKENT'EVICH
Score 2.5281782
Snippet biochemistry, pharmacy. SUBSTANCE: invention relates to the improved medicinal form, suppositorium. Suppositorium has a double-strand complex of...
SourceID epo
SourceType Open Access Repository
SubjectTerms HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Title IMPROVED MEDICINAL FORM OF INTERFERON INDUCTOR
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20010210&DB=EPODOC&locale=&CC=RU&NR=2162687C2
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LS8NAEB5KFfWmVbG-2IPkFk3TzaOHIHaT0Ip5EJLSW9lkE-ilLTbi33eyNtWL3oZdmH3AN4-dnRmABzEQNNcHlaoJYaq04IVqU0Oow0oX3GhMAtmtIQjNSUZf58a8A8s2F0bWCf2UxRERUQXivZbyevPziOXKv5Xbp3yJQ-tnP3VcpfWOm0bVmuKOHS-O3IgpjDlJpoQJAhMtd9tiKK0P0Iq2GjB4s3GTlLL5rVH8UziMkdmqPoNOuerBMWsbr_XgKNjFu5HcQW97Do_TIE6imecSWZFxGr68EfTgAhL5RNa19b0kCpF0M5ZGyQUQ30vZRMWFF_tDLpJsv8XhJXTR9y-vgHBuURt9xaGtF1QYnJujURMp1gTKpSrnfej_yeb6n7kbOPn-TKWjHL6Fbv3-Ud6hdq3ze3kvX24kemE
link.rule.ids 230,309,783,888,25576,76876
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LT8JAEJ4QNOJNUSM-92B6q0K7hXIgRrZtitIuaVrCjWy7NOECRGr8-05Xil70NtlNZh_JN4-dnRmAB9mRNDU6ud6WsqvTTGS6TS2pm7khhVWaBKpbQxB2_YS-zqxZDZZVLoyqE_qpiiMiojLEe6Hk9ebnEctRfyu3T-kSh9bPXjxwtMo7LhtVtzVnOHAn3OFMY2wQJVoYITDRcrd7DKX1AVrYvRIM7nRYJqVsfmsU7wQOJ8hsVZxCbbFqQoNVjdeacBTs4t1I7qC3PYPHUTCJ-NR1iKrIOApfxgQ9uIBwj6i6tp4b8RBJJ2Exj86BeG7MfB0Xnu8POY-S_RbNC6ij77-4BCJEj9roK5q2kVFpCdHt98tIcVuiXMpT0YLWn2yu_pm7h4YfB-P5eBS-XcPx98cqA2XyDdSL94_FLWraIr1Td_QFVuh9VA
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=IMPROVED+MEDICINAL+FORM+OF+INTERFERON+INDUCTOR&rft.inventor=FADEEVA+L.L&rft.inventor=KASPAROV+A.A&rft.inventor=SAMOJLENKO+I.I&rft.inventor=SEMENOVA+T.B&rft.date=2001-02-10&rft.externalDBID=C2&rft.externalDocID=RU2162687C2